Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.

Delhi police on Tuesday argued in the Delhi High Court that February 2020 riots were a result of “clinical and pathological conspiracy” executed with a “diabolical intention and ruthless intensity”.

After completing Yale SOM’s MBA for Executives program, Alicia Hardy ’23, Amaziah Coleman ’24, and Steven Starks ’23 returned to their workplaces with proposals to make quality healthcare more ...

About NXC-201 NXC-201 is a sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy. Initial data from Phase 1b/2 ex-U.S. study NEXICART-1 has demonstrated high complete ...

Act (UAPA), the Delhi Police opposed the bail of Sharjeel Imam, Umar Khalid, and others accused in the case involving the "larger conspiracy" behind the Delhi riots of 2020. Additional Solicitor ...

WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the ...

Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic ...

Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure ...

Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the ...

Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for the treatment of diabetic macular edema in October ...

Clinical trials are underway in Colorado for a new drug that could extend a dog's lifespan. Loyal, a San Francisco based ...

PharmaEssentia is looking to expand the reach of its FDA-approved rare blood cancer treatment Besremi to another rare blood ...